Alteration in NMDAR-related amino acids in first episode psychosis.

Abstract

The aim of the present study was to explore the role of N-methyl-D-aspartate receptor (NMDAR) related amino acids in drug-naive first episode psychosis (FEP) patients. The medication naïve patients with FEP (n=40) and healthy volunteers with no family history of schizophrenia (n=35) were recruited to the study and followed up for 10weeks. Liquid chromatography-mass spectrometry method was used to measure plasma levels of the amino acids. The plasma glutamine, glutamic acid, proline, serine, asparagine, and hydroxyproline levels were significantly higher in the FEP patients compared to healthy controls (p values<.0001). The glutamine/glutamic acid ratio in FEP patients was not different from the healthy controls (p>.05). After the antipsychotic treatment, plasma glutamic acid, proline, and hydroxyproline levels were significantly increased (p values<.05) while the asparagine level and glutamine/glutamic acid ratio were decreased (p values<.05). The serine and glutamine levels did not show any differences with the treatment (p>.05). The initial plasma glutamine levels were negatively correlated with the initial Scale for the Assessment of Positive Symptoms (SAPS) score (r=-.45, p=.003). The initial plasma proline levels were negatively correlated with the initial and follow-up SAPS scores (r=-.51 and -.39, p values<.05). The initial plasma proline and hydroxyproline levels were both negatively correlated with the initial Brief Psychiatric Rating Scale score (r=-.37, p=.017 and r=-.33, p=.033, respectively). Increase in NMDAR-related amino acid levels during the FEP may be a compensatory response to glutamatergic hypofunction. Their plasma levels were significantly correlated with several psychotic symptoms before and after 10-week treatment. Antipsychotic treatment has differential effects on the plasma levels of these amino acids.